Cart
sales@molnova.com
DJ4
CAS No. 1681020-24-5
DJ4( —— )
Catalog No. M37030 CAS No. 1681020-24-5
DJ4 induces a dose-dependent pro-apoptotic effect in the micromolar range.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 34 | In Stock |
|
| 5MG | 59 | In Stock |
|
| 10MG | 91 | In Stock |
|
| 25MG | 177 | In Stock |
|
| 50MG | 256 | In Stock |
|
| 100MG | 364 | In Stock |
|
| 200MG | 496 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDJ4
-
NoteResearch use only, not for human use.
-
Brief DescriptionDJ4 induces a dose-dependent pro-apoptotic effect in the micromolar range.
-
DescriptionDJ4 induces a dose-dependent pro-apoptotic effect in the micromolar range.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1681020-24-5
-
Formula Weight348.42
-
Molecular FormulaC19H16N4OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(\C=1C=2C(NC1)=NC=CC2)=C/3\SC(NCCC4=CC=CC=C4)=NC3=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Bomedemstat ditosyla...
Bomedemstat ditosylate (IMG-7289 ditosylate) is an orally active lysine-specific demethylase 1 (LSD1) inhibitor with antitumor activity that potentiates the response to PD-1 inhibition in a homozygous model of SCLC, inhibits cancer cell proliferation, and induces apoptosis.
-
N-Hexanoyl-D-sphingo...
C6-ceramide, a ceramide pathway activator, shows activity against a variety of cancer cell lines. C6-ceramide can be used as an adjuvant for chemotherapeutic agents, to enhance anti-tumor effects.
-
PCC0208017
PCC0208017 is an inhibitor of MARK3 and MARK4 with IC50s of 1.8 and 2.01 nM. PCC0208017 disrupts microtubule dynamics and displays potent antitumor activity.
